Application Of Omics-based Strategies For Improved Diagnosis And Treatment Of Endocrine Hypertension
Funder
National Health and Medical Research Council
Funding Amount
$461,322.00
Summary
Arterial hypertension affects up to 45% of the general population and is responsible for 7.1 million deaths per year worldwide. We will define specific omics profiles for patients with a range of hypertension-related disorders by integrating high throughput genetics, genomics and metabolomics data. This should allow identification of patients with preclinical phenotypes along with those hypertensives that cluster into specific endocrine groups who may benefit from personalised treatment.
A Novel Approach To Streamlining The Diagnosis Of Primary Aldosteronism
Funder
National Health and Medical Research Council
Funding Amount
$269,463.00
Summary
This study will assess a new clinical test used to diagnose a potentially curable form of high blood pressure called primary aldosteronism (PA). If successful, the test will greatly streamline and simplify the diagnosis of this condition, with the potential for enormous cost savings and a markedly increased rate of diagnosis of patients with PA who can then benefit from optimal treatment and improved quality of life.
Stress And HPA Axis Function In First-episode Psychosis: Relationship With Clinical Features And Dynamic Brain Changes
Funder
National Health and Medical Research Council
Funding Amount
$182,378.00
Summary
This research examines the role of stress in the progression of psychotic disorders- a group of severe mental illnesses that include schizophrenia. We will investigate whether patients with psychosis who have an abnormal response to stress experience more severe and distressing symptoms as well as brain volume changes during the initial phase of illness. The results of this research could have important implications for the development of more effective treatments for these disorders.